View image online ( illustration showing action of a GLP-1 receptor agonist For the first time, a pharmacotherapy for overweight and obesity has been shown to reduce cardiovascular events in patients with established cardiovascular disease (CVD) in the absence of type 2 diabetes
In people for whom ADHD treatment is unsafe or ineffective, it could be an alternative
It may help in many other conditions, like sepsis, which is caused by an infection that leads to an imbalanced immune response involving pro (e.g., TNF-, IL-1, IL-2, IL-6) and anti-inflammatory (e.g., IL-10, IL-4, IL-7) cytokines
If you take it in the morning one day and at night the next, you may not maintain steady levels in your system
Best Practices to Stay on Track with GLP-1 Injections Adherence is a major predictor of treatment success
The clinical evidence linking GLP-1 medications to persistent gastroparesis remains evolving and somewhat controversial